logo
Sign in

JSPR Stock Price, Chart, Stats & News

Jasper Therapeutics, Inc.
Save
8.13M
Market cap
Current P/E
Forward P/E

JSPR chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
Operating margin
Pretax margin
Net margin
Effective tax rate
ROA
-158.38%
ROE
-261.95%
D/E
0.15x
Interest coverage ratio

JSPR valuation

P/E
P/S
P/B
1.50x
P/CF
-0.23x
P/FCF
-0.22x
P/OCF
-0.23x
PEG
-0.10x
EV multiple
-0.72x

About

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for hematopoietic stem cell transplantation and gene therapies. Its core mission is to develop and commercialize conditioning agents and advanced stem cell engineering methods. These advancements aim to expand the utility of stem cell transplantation and ex vivo gene therapy, a process involving genetic modification of cells outside the body before their transplantation.

Similar securities

Based on sector and market capitalization

Report issue